Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
covid-19_vaccines:efficacy [2022/04/05 10:04] mathew | covid-19_vaccines:efficacy [2022/10/21 18:11] (current) xinke [Waning Efficacy] | ||
---|---|---|---|
Line 24: | Line 24: | ||
* The authors inexplicably failed to make an expected standard risk-adjustment in their calculations, | * The authors inexplicably failed to make an expected standard risk-adjustment in their calculations, | ||
* Sep 28, 2021 - Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers((September 28, 2021 | Jean-Louis Bayart et al | Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers | [[https:// | * Sep 28, 2021 - Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers((September 28, 2021 | Jean-Louis Bayart et al | Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers | [[https:// | ||
+ | * Nov 18, 2021 - Isolation of 4000 SARS-CoV-2 shows that contagiousness is associated with viral load, not vaccine or symptomatic status((November 18, 2021 | Celine Boschi et al | Emerging Microbes and Infections | Isolation of 4000 SARS-CoV-2 shows that contagiousness is associated with viral load, not vaccine or symptomatic status | [[https:// | ||
+ | * June 23, 2022 - Comparative effectiveness and durability of COVID‐19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign((June 23, 2022 | Theodore Lytras et al | J Med Virol | Comparative effectiveness and durability of COVID‐19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign | [[https:// | ||
+ | * The lead author and a co-authored also authored a paper in support of lockdowns. That co-author is a spokesman with a spokesman for the [[Hellenic Ministry of Health]].((February, | ||
+ | * The waning of VE from 90% to 80% is substantially less than from other reported retrospective results. | ||
+ | * Says the olderly are more than 1000x as at risk as the young without even a word suggesting that absolute benefits may not justify the risks for the young. | ||
+ | |||
==== Surveillance Data ==== | ==== Surveillance Data ==== | ||
Line 44: | Line 50: | ||
* Deaths have increased 46.3% worldwide. | * Deaths have increased 46.3% worldwide. | ||
- | * [[:Mathew Crawford]] wrote at [[:Rounding the Earth]] about how there is no distinction in any [[:COVID-19 vaccine trials]] data or subsequent retrospective analyses that is inconsistent with the [[: | + | * [[:Mathew Crawford]] wrote at [[:Rounding the Earth]] about how there is no distinction in any [[COVID-19 vaccines:COVID-19 vaccine trials]] data or subsequent retrospective analyses that is inconsistent with the [[: |
=== Selective Reporting === | === Selective Reporting === | ||
Line 50: | Line 56: | ||
=== Local Observational Studies and Anecdotes === | === Local Observational Studies and Anecdotes === | ||
- | Little difference in [[: | + | Little difference in [[: |
Despite a 99.5% double-vaccination rate, Co Waterford, Ireland had the highest case rate in all of Ireland in early November, 2021.((November 6, 2021 | [[:Sky News]] | [[https:// | Despite a 99.5% double-vaccination rate, Co Waterford, Ireland had the highest case rate in all of Ireland in early November, 2021.((November 6, 2021 | [[:Sky News]] | [[https:// | ||
+ | |||
+ | More recently, Rintrah wrote on the vaccine lack of effectiveness in Denmark: | ||
+ | |||
+ | https:// | ||
+ | |||
+ | ==== Efficacy Specific to Those Recovered From COVID-19 ==== | ||
+ | * Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19((March 31, 2022 | Ariel Hammerman et al | [[:NEJM]] | Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19 | [[https:// | ||
+ | |||
==== Booster Efficacy ==== | ==== Booster Efficacy ==== | ||
Line 63: | Line 77: | ||
=== Waning Booster Efficacy === | === Waning Booster Efficacy === | ||
- | Medpage Today reported that COVID vaccine booster efficacy may want quickly.((December 28, 2021 | MedPage Today | [[https:// | + | Medpage Today reported that COVID vaccine booster efficacy may wane quickly.((December 28, 2021 | MedPage Today | [[https:// |
==== Efficacy by Variant ==== | ==== Efficacy by Variant ==== | ||
Line 73: | Line 87: | ||
=== Efficacy vs. Delta === | === Efficacy vs. Delta === | ||
* Aug 12, 2021 - Bernal et al: Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant ((August 12, 2021 | Bernal et al | [[:New England Journal of Medicine]] | [[https:// | * Aug 12, 2021 - Bernal et al: Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant ((August 12, 2021 | Bernal et al | [[:New England Journal of Medicine]] | [[https:// | ||
+ | * June 23, 2022 - Comparative effectiveness and durability of COVID‐19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign((June 23, 2022 | Theodore Lytras et al | J Med Virol | Comparative effectiveness and durability of COVID‐19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign | [[https:// | ||
+ | * This study from Greece concludes 90% VE which waves to 80% over six months, consistent over age bands. | ||
=== Efficacy vs. Omicron === | === Efficacy vs. Omicron === |